Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Meanwhile, some people can have a series of less intense ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

The interplay between graph analytics and large language models (LLMs) represents a promising frontier for advancing ...

A 3D-printed miniature model of Elon Musk and the X logo are seen in this illustration taken January 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Banks led by Morgan Stanley have sold to ...

The apipeline_enqueue_documents and apipeline_process_enqueue_documents functions allow you to perform incremental insertion of documents into the graph. This is useful for scenarios where you want to ...